| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L01XX58 |
| UNII: | 71596A9R13 |
| InChI Key | FBKMWOJEPMPVTQ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C11H13BrFN7O4S |
| Molecular Weight | 438.24 |
| AlogP | 0.42 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 167.76 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 25.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Indoleamine 2,3-dioxygenase inhibitor | PubMed |
| Primary Target | |
|---|---|
| indoleamine 2,3-dioxygenase 1 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
8-13 | 3-125 | 3460 | 21700-21700 | 92-101 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Melanoma | 3 | D008545 | ClinicalTrials |
| Melanoma | 3 | D008545 | ClinicalTrials |
| Head and Neck Neoplasms | 3 | D006258 | ClinicalTrials |
| Urogenital Neoplasms | 3 | D014565 | ClinicalTrials |
| Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Carcinoma, Pancreatic Ductal | 2 | D021441 | ClinicalTrials |
| Hereditary Breast and Ovarian Cancer Syndrome | 2 | D061325 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Thymoma | 2 | D013945 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Peritoneal Neoplasms | 1 | D010534 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1204669-58-8 |
| ChEMBL | CHEMBL3545369 |
| DrugBank | DB11717 |
| FDA SRS | 71596A9R13 |
| Guide to Pharmacology | 8221 |
| PDB | BBJ |
| PubChem | 135564890 |
| SureChEMBL | SCHEMBL18823200 |
| ZINC | ZINC000113208009 |